207 related articles for article (PubMed ID: 32539808)
1. Cerebrospinal fluid cytokines in metastatic group 3 and 4 medulloblastoma.
Low SYY; Bte Syed Sulaiman N; Tan EEK; Ng LP; Kuick CH; Chang KTE; Tang PH; Wong RX; Looi WS; Low DCY; Seow WT
BMC Cancer; 2020 Jun; 20(1):554. PubMed ID: 32539808
[TBL] [Abstract][Full Text] [Related]
2. Correlation between polysialic-neural cell adhesion molecule levels in CSF and medulloblastoma outcomes.
Figarella-Branger D; Dubois C; Chauvin P; De Victor B; Gentet JC; Rougon G
J Clin Oncol; 1996 Jul; 14(7):2066-72. PubMed ID: 8683238
[TBL] [Abstract][Full Text] [Related]
3. IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma.
Svalina MN; Kikuchi K; Abraham J; Lal S; Davare MA; Settelmeyer TP; Young MC; Peckham JL; Cho YJ; Michalek JE; Hernandez BS; Berlow NE; Jackson M; Guillaume DJ; Selden NR; Bigner DD; Nazemi KJ; Green SC; Corless CL; Gultekin S; Mansoor A; Rubin BP; Woltjer R; Keller C
Sci Rep; 2016 Jun; 6():27012. PubMed ID: 27255663
[TBL] [Abstract][Full Text] [Related]
4. Young investigator challenge: Cytomorphologic analysis of cerebrospinal fluid in 70 pediatric patients with medulloblastoma and review of the literature focusing on novel diagnostic and prognostic tests.
Damiani D; Suciu V; Andreiuolo F; Calderaro J; Vielh P
Cancer Cytopathol; 2015 Nov; 123(11):644-9. PubMed ID: 26769585
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid M staging for medulloblastoma: reappraisal of Chang's M staging based on the CSF flow.
Phi JH; Lee J; Wang KC; Cho BK; Kim IO; Park CK; Kim CY; Ahn HS; Kim IH; Kim SK
Neuro Oncol; 2011 Mar; 13(3):334-44. PubMed ID: 21134897
[TBL] [Abstract][Full Text] [Related]
6. Histologic Correlates of Molecular Group 4 Pediatric Medulloblastoma: A Retrospective Canadian Review.
Triscott J; Yip S; Johnston D; Michaud J; Rassekh SR; Hukin J; Dunn S; Dunham C
Pediatr Dev Pathol; 2021; 24(4):309-317. PubMed ID: 33749384
[TBL] [Abstract][Full Text] [Related]
7. Serial assessment of measurable residual disease in medulloblastoma liquid biopsies.
Liu APY; Smith KS; Kumar R; Paul L; Bihannic L; Lin T; Maass KK; Pajtler KW; Chintagumpala M; Su JM; Bouffet E; Fisher MJ; Gururangan S; Cohn R; Hassall T; Hansford JR; Klimo P; Boop FA; Stewart CF; Harreld JH; Merchant TE; Tatevossian RG; Neale G; Lear M; Klco JM; Orr BA; Ellison DW; Gilbertson RJ; Onar-Thomas A; Gajjar A; Robinson GW; Northcott PA
Cancer Cell; 2021 Nov; 39(11):1519-1530.e4. PubMed ID: 34678152
[TBL] [Abstract][Full Text] [Related]
8. Correlation of MRI and CSF cytology in the diagnosis of medulloblastoma spinal metastases.
Harrison SK; Ditchfield MR; Waters K
Pediatr Radiol; 1998 Aug; 28(8):571-4. PubMed ID: 9716623
[TBL] [Abstract][Full Text] [Related]
9. Preoperative Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with the Prognosis of Group 3 and Group 4 Medulloblastoma.
Li K; Duan WC; Zhao HB; Wang L; Wang WW; Zhan YB; Sun T; Zhang FJ; Yu B; Bai YH; Wang YM; Ji YC; Zhou JQ; Liu XZ; Zhang ZF; Zhang ZY
Sci Rep; 2019 Sep; 9(1):13239. PubMed ID: 31519974
[TBL] [Abstract][Full Text] [Related]
10. Proteome and miRNome profiling of microvesicles derived from medulloblastoma cell lines with stem-like properties reveals biomarkers of poor prognosis.
Kaid C; Assoni A; Marçola M; Semedo-Kuriki P; Bortolin RH; Carvalho VM; Okamoto OK
Brain Res; 2020 Mar; 1730():146646. PubMed ID: 31917138
[TBL] [Abstract][Full Text] [Related]
11. Recurrent Cerebellar Desmoplastic/Nodular Medulloblastoma in Cerebrospinal Fluid (CSF) in the Elderly. A Cytologic Diagnosis.
Kalogeraki A; Tamiolakis D; Mavrigiannaki P; Karvelaskalogerakis M; Datseri G; Agelaki S; Papadopoulos S
Rom J Intern Med; 2016; 54(2):137-9. PubMed ID: 27352444
[TBL] [Abstract][Full Text] [Related]
12. Proteomic profiling of medulloblastoma reveals novel proteins differentially expressed within each molecular subgroup.
Narayan V; Jaiswal J; Sugur H; Sd S; Rao S; Chatterjee A; Gowda H; A A; Somanna S; Santosh V
Clin Neurol Neurosurg; 2020 Sep; 196():106028. PubMed ID: 32580068
[TBL] [Abstract][Full Text] [Related]
13. Postoperative evaluation for disseminated medulloblastoma involving the spine: contrast-enhanced MR findings, CSF cytologic analysis, timing of disease occurrence, and patient outcomes.
Meyers SP; Wildenhain SL; Chang JK; Bourekas EC; Beattie PF; Korones DN; Davis D; Pollack IF; Zimmerman RA
AJNR Am J Neuroradiol; 2000 Oct; 21(9):1757-65. PubMed ID: 11039362
[TBL] [Abstract][Full Text] [Related]
14. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
[TBL] [Abstract][Full Text] [Related]
15. Medulloblastoma: Distinctive Histo-Molecular Correlation with Clinical Profile, Radiologic Characteristics, and Surgical Outcome.
Narayan V; Sugur H; Jaiswal J; Arvinda HR; Arivazhagan A; Somanna S; Santosh V
Pediatr Neurosurg; 2019; 54(5):329-340. PubMed ID: 31480064
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of intracranial cerebrospinal fluid cytology in staging pediatric medulloblastomas, supratentorial primitive neuroectodermal tumors, and ependymomas.
Terterov S; Krieger MD; Bowen I; McComb JG
J Neurosurg Pediatr; 2010 Aug; 6(2):131-6. PubMed ID: 20672933
[TBL] [Abstract][Full Text] [Related]
17. Exploring genetic alterations in circulating tumor DNA from cerebrospinal fluid of pediatric medulloblastoma.
Sun Y; Li M; Ren S; Liu Y; Zhang J; Li S; Gao W; Gong X; Liu J; Wang Y; Du S; Sun L; Wu W; Tian Y
Sci Rep; 2021 Mar; 11(1):5638. PubMed ID: 33707557
[TBL] [Abstract][Full Text] [Related]
18. Medulloblastoma metastatic to the suprasellar region at diagnosis: a report of six cases with clinicopathologic correlation.
Helton KJ; Gajjar A; Hill DA; Boop FA; Kun LE; Langston JW
Pediatr Neurosurg; 2002 Sep; 37(3):111-7. PubMed ID: 12187055
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal chemotherapy delivered by a lumbar-thecal catheter in metastatic medulloblastoma: a case illustration.
Clayton J; Vloeberghs M; Jaspan T; Walker D; MacArthur D; Grundy R
Acta Neurochir (Wien); 2008 Jul; 150(7):709-12. PubMed ID: 18401539
[TBL] [Abstract][Full Text] [Related]
20. Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination.
Martirosian V; Deshpande K; Zhou H; Shen K; Smith K; Northcott P; Lin M; Stepanosyan V; Das D; Remsik J; Isakov D; Boire A; De Feyter H; Hurth K; Li S; Wiemels J; Nakamura B; Shao L; Danilov C; Chen T; Neman J
Cell Rep; 2021 Jun; 35(13):109302. PubMed ID: 34192534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
